We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Utilizing Assessment Tools in Insomnia
Michael E. Yurcheshen, MD, FAASM
Early-Stage Alzheimer’s Disease: New Therapies for Mild Cognitive Impairment
Sharon Cohen, MD, FRCPC
Richard S. Isaacson, MD
Marwan Noel Sabbagh, MD, FAAN, CCRI
Disparities and Inequities in the Diagnosis and Care of Vulnerable Patient Populations
Novel and Emerging Disease Modifying Therapies for Mild Cognitive Impairment Due to AD: Efficacy and Safety of New DMTs for MCI
Evidence-Based Discussion of the New and Emerging DMT Treatment Strategies for MCI
Challenges in Recognizing and Diagnosing MCI in AD Earlier
New Data on the Pathophysiology of MCI and Dementia
Evolving Treatment Paradigms For Mild Cognitive Impairment and Dementia: How New DMTs Will Fit Into Clinical Practice
Expert Opinion on How the New DMTs Fit into Everyday Clinical Practice
Professional Recommendations of Clinically Validated Tools Used to Diagnose MCI in AD
Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups
Christina Finch, MD
Roundtable: Experts Recommend Tools to Diagnose and Monitor Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Atul Malhotra, MD
How to Identify Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Neomi Shah, MD, MPH, MSc
The Epidemiology of Sleepiness in Obstructive Sleep Apnea
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education